Клинико-иммунологическая эффективность комплексной терапии аденомиоза с использованием ронколейкина

On the basis of clinical and immunological data obtained it has been pathogenically determined that systemic and local introduction of Ronkoleykin into adenomyosis complex therapy is preferable. Having compared the results of clinical and immunological therapy with those of traditional one it has been proved the effectiveness of the former. Thus, after the application of Ronkoleykin into complex therapy it has been clinically stated the following: an 1,9 increase of wished pregnancy, 1,8 increase of restoring menstrual function, 1,7 of pain syndrome disappearance, 1,6 reduction of uterus extend, absence of relapses. Besides all that it has been immunologically estimated both the normal popp-ularisation and subpoppularisation of lymphocytes on systemic immunity, restoration of cytokine consentration in peripheral and cervicovaginal mucus as well. All the above mentioned allow us to putting into clinical practice the application of Ronkoleykin in the adenomyosis complex therapy.